 |
|
Examining Patterns of Polypharmacy in Bipolar Disorder: Findings from the REAP-BD, Korea
Kiwon Kim, Hyunju Yang, Euihyeon Na, Hoseon Lee, Ok-Jin Jang, Hyung-Jun Yoon, Hong Seok Oh, Byung-Joo Ham, Seon-Cheol Park, Shih-Ku Lin, Chay Hoon Tan, Naotaka Shinfuku, Yong Chon Park
Psychiatry Investig. 2019;16(5):397-402. Published online 2019 May 23 DOI: https://doi.org/10.30773/pi.2019.02.26.4
|
|
Polypharmacy in Outpatients with Bipolar Disorder: Associated Factors and Treatment Characteristics in Türkiye
Neriman ARAS, Fatma ÇOKER, Nihan KÜÇÜK
Sakarya Medical Journal.2023;[Epub] CrossRef Which factors delay treatment in bipolar disorder? A nationwide study focussed on duration of untreated illness
Massimiliano Buoli, Bruno Mario Cesana, Andrea Fagiolini, Umberto Albert, Giuseppe Maina, Andrea de Bartolomeis, Maurizio Pompili, Emi Bondi, Luca Steardo, Mario Amore, Antonello Bellomo, Alessandro Bertolino, Marco Di Nicola, Guido Di Sciascio, Andrea Fi
Early Intervention in Psychiatry.2021; 15(5): 1136. CrossRef Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics
Yoo Hyun Um, Tae-Won Kim, Ho-Jun Seo, Seung-Chul Hong, Sung-Min Kim, Ji-Hye Oh, Jong-Hyun Jeong
International Clinical Psychopharmacology.2020; 35(5): 263. CrossRef Clinical Characteristics of Bipolar Disorder Patients with Mood Stabilizer-Induced Cognitive Side Effects findings from the REAP-BD Survey in Korea
Hihyun Shin, Jin Hee Choi, Hyungseok So, Hayun Choi, Yong Chon Park, Chay Hoon Tan, Shih-ku Lin, Naotaka Shinfuku, Seon-Cheol Park, Kiwon Kim
Journal of Korean Neuropsychiatric Association.2020; 59(3): 277. CrossRef
|